XOFLX
LIVE

Serial Number

79417533

Owner

Oxford Genetics Ltd

Attorney

KATE SHERLOCK

Filing Date

Jan 29, 2025

Add to watchlist:

No watchlists yet
View on USPTO

XOFLX Trademark

Serial Number: 79417533 • Registration: 8237469

XOFLX is a trademark filed by Oxford Genetics Ltd on January 29, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Oxford Genetics Ltd (12 trademarks)

Medawar Centre,

Entity Type: 99

Trademark Details

Filing Date

January 29, 2025

Registration Date

May 5, 2026

Published for Opposition

March 17, 2026

Goods & Services

Product design and development services relating to the creation and alteration of chemical and biological reagents; scientific design services relating to the creation and alteration of nucleic acids in the nature of nucleic recombinant acids and synthetic deoxyribonucleic acids; scientific design services, namely, development relating to the creation and alteration of recombinant viruses; scientific design services relating to the creation and alteration of lentiviruses, lentivirus particles and lentivirus plasmids; scientific research, product development and bioengineering services relating to lentiviruses; drug discovery services; scientific design services relating to the creation and alteration of cell lines, elementary cells and parts thereof being drug discovery services; scientific design services, namely, development relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services

Chemical and biological preparations for use in science and industry; nucleic acids for laboratory use; nucleic recombinant acids for laboratory use, synthetic deoxyribonucleic acids for laboratory use; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes, namely, immortalized mammalian cell lines; microorganisms for non-medical purposes being cultures of microorganisms other than for medical and veterinary use; human and animal cells and parts thereof for scientific and research purposes, namely, immortalized mammalian cell lines; cultures of microorganisms for scientific and research purposes; viral vectors being chemicals and biological preparations for use in science and industry; lentiviruses, lentivirus particles and lentivirus plasmids being chemicals and biological preparations, all for scientific and research purposes

Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes, namely, immortalized mammalian cell lines; preparations of microorganisms for medical and veterinary purposes; viral vectors being biological preparations derived from tissue cultures for medical and veterinary purposes; lentiviruses, lentivirus particles and lentivirus plasmids being biological preparations, all for medical and veterinary use, namely, for the treatment of cardiovascular, degenerative, dermatological, endocrine, gastrointestinal, genetic, gynaecological, neurological, infectious, immunological, metabolic, oncological, ophthalmic, respiratory and urological disorders and diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 5, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 5, 2026 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Mar 19, 2026 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 19, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 22, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 22, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 22, 2026 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 21, 2026 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Jan 21, 2026 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 21, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 21, 2026 REAP
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 19, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 19, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 19, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 19, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 19, 2025 COAR
REFUSAL PROCESSED BY IB
Sep 5, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 18, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 18, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 11, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jul 10, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 9, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 23, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2025 REPR